Received by email:

File: NRDEC14.docx


THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

For Immediate Release                                                                                                 
--->       December 14, 2017

VALENS GROWORKS UPSIZES PRIVATE PLACEMENT

Vancouver, B.C., December 14, 2017 - Valens GroWorks Corp. (CSE: VGW) (the "Company" or "Valens"), a multi-licenced, v
--->ertically integrated provider of cannabis products, announces that is increasing its previously announced private plac
--->ement to an offering of 2,000,000 units of the Company (the "Units") at a price of $1.00 per Unit for gross proceeds o
--->f up to $2,000,000 (the "Offering"). Following the previously announced closed tranches totalling $712,700, this incre
--->ase will accommodate an additional $1,287,300 as a potential final tranche. The Corporation intends to use the net pro
--->ceeds from the Offering to advance the operations at its 17,000 sq.ft. facility in Kelowna and complete its initial ca
--->nnabis crop. Remaining proceeds, if any, will be used for general corporate purposes.
Each Unit consists of one common share of the Company (a "Common Share") and one-half of a Common Share purchase warra
--->nt (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share at a p
--->rice of $1.50 for a period of 12 months from the closing of the Offering, subject to the acceleration provision descri
--->bed below. The Units are being made available by way of prospectus exemptions in Canada and in such other jurisdiction
--->s as the Company may agree where the Units can be issued on a private placement basis, exempt from any prospectus, reg
--->istration or other similar requirements.  
The Company will be entitled to accelerate the expiry date of the Warrants to the date that is 30 days following the d
--->ate the Company issues a news release announcing that the published closing price of the Common Shares on the Canadian
---> Securities Exchange (the "CSE") has been equal to or greater than $2.00 for ten consecutive trading days after the ho
--->ld period on the Common Shares has expired.  
Closing of the Offering is subject to regulatory approval including that of the CSE. The Company may pay a finder's fe
--->e on the non-insider portion of the Offering within the amount permitted by the policies of the CSE. All securities is
--->sued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the dat
--->e of issuance in accordance with applicable securities legislation.
About Valens GroWorks Corp.
Valens GroWorks is Canadian publicly traded biotechnology company executing on its "plants to premium products" object
--->ives through two wholly-owned subsidiaries, located at the Company's expanding 17,000 sq.ft. facility on two acres in 
--->Kelowna, in the heart of British Columbia's Okanagan Valley. Subsidiary Valens Agritech ("VAL") is commencing cannabis
---> production and sales under a Health Canada Dealer's License, and is also a late-stage license applicant to cultivate 
--->medical marijuana under the ACMPR for individual patients. Subsidiary Supra THC Services ("Supra") is a Health Canada 
--->licensed cannabis testing lab providing sector-leading analytical and proprietary services to Licensed Producers, ACMP
--->R patients, and the natural health products industry.
Supra has partnered with Thermo Fisher Scientific to develop a "Centre of Excellence in Plant Based Medicine Analytics
--->" in Kelowna, and both subsidiaries are involved in a collaborative research partnership with British Columbia-based u
--->niversities UBC Okanagan and Thompson Rivers to explore the vast range of bioproducts that can be made from cannabis p
--->lant materials. A supply and sales agreement with Canopy Growth Corporation (TSX: WEED) provides for the distribution,
---> marketing and sale of a portion of the Company's branded products through Canopy Growth's extensive CraftGrow distrib
--->ution network. For more information, please visit http:/valensgroworks.com, http://www.valensagritech.com and http://w
--->ww.suprathc.ca.
On behalf of the Board of Directors,
VALENS GROWORKS CORP.

(signed) "Rob van Santen" Chief Financial Officer
For further information, please contact:
Greg Patchell  Telephone: +1.250.860.8634
Notice regarding Forward Looking Statements
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable
---> securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "cont
--->inue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "po
--->sitioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statem
--->ents are only predictions. Various assumptions were used in drawing the conclusions or making the projections containe
--->d in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions
---> and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertaint
--->ies and other factors that could cause actual events or results to differ materially from those projected in the forwa
--->rd-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to
---> update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, 
--->except as expressly required by applicable law.
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We
---> seek Safe Harbour.